Edwards Lifesciences Corporation (EW) has a consensus analyst rating of Buy, based on 48 analysts covering the stock. Of those, 32 recommend buying, 16 recommend holding, and 0 recommend selling.
The analyst consensus price target for EW is $96.38, representing a +23.2% upside from the current price of $78.2. Price targets range from a low of $87.00 to a high of $110.00.
